Symmetry Medical SMA announced the sale of its OEM Solutions business to Tecomet for $450 million, or $7.50 per share. Symmetry Medical also announced better than expected second quarter earnings.
The OEM business made up 79.9 percent of second quarter revenue at $80.9 million. The OEM business grew 5.5 percent year over year whereas the other business, Symmetry Surgical, contracted by 8.7 percent.
Related: Bloomberg Messaging Could Be Replaced By A Startup
President and CEO Thomas Sullivan commented on the deal, “This morning we announced a proposed transaction to sell our OEM Solutions business and concurrently transfer to Symmetry Medical, Inc.'s shareholders ownership in a new company holding our Symmetry Surgical business. We believe it will maximize shareholder value by providing a premium valuation for the OEM Solutions business along with the upside potential of Symmetry Surgical in the large global market for surgical instruments.”
Second quarter revenue totaled $101.3 million, 2.2 percent better than the analyst estimate of 99.2 million. This generated EPS of $0.17 versus $0.12.
Shares of Symmetry Medical are unchanged in early Monday trading. The issue closed at $8.81 Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.